Work

Abstract PS3-07-02: An Exploratory Clinical Trial of CDK4/6 Inhibitor Dalpiciclib Combined with Aromatase Inhibitors as Neoadjuvant Therapy for Stage II-III HR-positive HER2-negative Breast Cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-07-02

Authors: Q. Yang, W. Chen, S. Chen, M. Meng, Q. Yang, G. Lin, L. Lin, Z. Zheng, R. Zeng, B. Chen, W. Li, Q. Zhao

Institutions: Xiamen University, First Affiliated Hospital of Xiamen University, Zhongshan Hospital of Xiamen University, Fujian Medical University, Putian University, Second Affiliated Hospital of Fujian Medical University

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130737026

Cites:

Cited by:

Related to: